The initiative aimed to identify the organisations following the best practices in people processes. It’s an initiative that recognises a company which supports successful ... Mar 15
In line with its mission of enabling the ease of doing business for Indian merchants, Shiprocket Capital promises to transform the financing landscape for emerging ... Dec 06
This addition to EQUIPPP’s team is in alignment with realizing the MOU with BSE to fuel the growth of the Social Stock Exchange, a ... Sep 23
It is important to raise awareness of these challenges and work towards creating more inclusive and supportive societies that value and empower individuals with albinism. ... Jun 13
Ayurveda startup NirogStreet raises INR 100 Crores. The startup is planning to use the funds to intensify its supply chain, service offerings, and technology. ... Nov 22
Fitterfly, a Mumbai-based health tech business, would utilize the funding to strengthen its technological stack and branding, as well as expand the scope of ... Jul 21
As the Insurtech sector rises so does Onsurity, the Indianinsurtech player rises. Even after receiving its Series A fund of $16 million, will Onsurity achieve ... Aug 18
The latest studies claim 76% efficacy, DSMB still has doubts... Mar 25
Sputnik V phase 3 trials cleared by the government... Jan 16
Preliminary data from the non-powered U.S. Phase 2 study of 40 hospitalized patients shows that orally-administered opaganib was safe, with no material ... Jan 02
Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication ... Dec 22
The results also show that opaganib inhibits SARS-CoV-2 virus replication and proinflammatory markers in relevant preclinical models ... Dec 17
This agreement will support the ongoing efforts by the Ministry to secure early access to a COVID-19 vaccine for the people of Israel... Dec 05
The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia... Nov 23
This agreement comes as the UK continues its efforts to secure access to safe and effective COVID-19 vaccines... Nov 19
BioAegis Therapeutics announced that it has expanded its clinical trial in severe COVID-19 to additional sites in Europe.... Nov 16
The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), ... Nov 10
Johnson & Johnson said on Monday it had temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, ... Oct 13
Plus Therapeutics receives fast track designation from FDA for its novel glioblastoma treatment ... Sep 16
AstraZeneca closer to COVID vaccine as 3rd phase trial starts... Sep 01
A brief roundup of all the vaccines under development ... Aug 14
The vaccine was found to be safe, immunogenic and well tolerated in the pre-clinical toxicity studies, it also able to elicit high level of ... Aug 05
Serum Institute allowed to carry on final trials of the Oxford University vaccine... Aug 03
Finally WHO discontinues HCQ and Lopinavir/Ritonavir ... Jul 06
Investigators currently anticipate enrolling more than 1,000 participants... May 14
-Advertisements-
Monday, May 13, 2024
.jpeg)
